Trevena Inc reports results for the quarter ended in January - Earnings Summary

Trevena

15/05/2024 19:08

* Trevena Inc  TRVN.OQ  reported a quarterly adjusted loss
of 36
cents​​ per share for the quarter ended in January, higher than
the same quarter last year, when the company reported EPS of -81
cents.  The mean expectation of two analysts for the quarter was
for a loss of 47 cents per share. Wall Street expected
results to range from -57 cents to -37 cents per share.
    * Revenue rose 233.3% to $20.00 thousand from a year ago;
analysts
expected zero. 
    * Trevena Inc's reported EPS for the quarter was a loss
of 36
cents​.
    * Trevena Inc shares had fallen by 9.1% this quarter and
lost 42.1% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Trevena Inc is
$6.00 
This summary was machine generated from LSEG data May 15 at
06:07 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.47          -0.36          Beat
 Dec. 31 2023      -0.38          -1.06          Missed
 Sep. 30 2023      -0.15          -0.57          Missed
 Jun. 30 2023      -1.05          -0.69          Beat